Fact CheckerSign in

NCT06893055Recruiting

Strength-Endurance Circuit Training in Parkinson's Disease

Strength-Endurance Circuit Training in Parkinson's Disease: Effects on Disease Severity, Physical Performance, Blood Biomarkers and Quality of Life.

Source: ClinicalTrials.gov · Last updated 9 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this clinical trial is to determine whether adding strength training to aerobic training has a comparable or greater effect on the clinical status of Parkinson's disease patients than a standalone aerobic training. \- Does combined strength-endurance circuit training provide added benefits to physical performance, disease severity, blood biomarkers, and quality of life in PD patients compared to standalone aerobic training? Participants will: * undergo outcome measurements before and after the 12-week intervention and a 3-month follow-up measurement, * visit the clinic twice a week for 1-hour training sessions. * selected patients will be given a smartwatch with a pedometer that will count their average number of steps before, during and after the training period

Status (registry)
Recruiting
Study type
Interventional
Enrollment
90 (estimated)
First submitted
18 Mar 2025
Start date
3 Mar 2025
Primary completion date
Dec 2026
Lead sponsor
General University Hospital, Prague
NCT number
NCT06893055

What you commit to

  • Study type: Interventional
  • Planned participants: 90
  • From 3 Mar 2025 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • age ≥75 years

Other

  • Hoehn-Yahr Scale ≥ 2,5
  • deep brain stimulation
  • presence of freezing
  • Camptocormia
  • inability to walk without support
  • inability to perform study procedures
  • limiting co-morbidities
  • attendance at training sessions below 70%

Who the study is looking for

  • age ≥18 years
  • diagnosis of idiopathic Parkinson´s disease
  • Hoehn-Yahr Scale ≤ 2,5
  • stable dopaminergic medication

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague
Coordinator of this site? Confirm its status
PragueCzechiaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.